Apo-Efavirenz-Emtricitabine-Tenofovir 300 mg (Tenofovir Disoproxil Fumarate TABLET) 300 MG

APO-Efavirenz-Emtricitabine-Tenofovir 300 MG tablets combine three active ingredients for HIV treatment. This fixed-dose combination is designed to simplify therapy regimens. Learn more about this antiretroviral medication.

Strength

300 MG

Pack Size

30/90

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-Efavirenz-Emtricitabine-Tenofovir 300 MG tablets are used in the treatment of HIV infection. This combination therapy helps manage the virus by targeting different stages of its lifecycle. The medication is typically prescribed as part of a broader antiretroviral treatment plan to reduce viral load and improve immune function.

Side Effects

Common effects of APO-Efavirenz-Emtricitabine-Tenofovir 300 MG tablets may include dizziness, nausea, and rash. Some users report changes in dream patterns or mood. These effects vary among individuals and are not experienced by everyone taking the medication.

Precautions & Warnings

Handle APO-Efavirenz-Emtricitabine-Tenofovir 300 MG tablets with care, following healthcare provider instructions. Inform your provider about any existing medical conditions or allergies. Regular monitoring may be required during treatment to ensure safety and efficacy.

Avoid Interactions

APO-Efavirenz-Emtricitabine-Tenofovir 300 MG tablets may interact with other medications, including those metabolized by the liver. Avoid alcohol and consult your healthcare provider before taking any new supplements or medications. Certain antacids or medications affecting kidney function may require dosage adjustments.

Frequently Asked Questions

This medication is used in the treatment of HIV infection as part of a combination therapy regimen.

Follow the instructions provided by your healthcare provider, typically taken orally with or without food.

Common side effects may include dizziness, nausea, rash, and changes in dream patterns.

Consult your healthcare provider before combining with other medications, as interactions may occur.

Long-term use should be monitored by a healthcare provider to ensure ongoing safety and efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.